Tag Archives: Empa and HOCH Health Ostschweiz Explore Innovative Nanotherapy to Improve Brain Cancer Outcomes

Empa Researchers Develop Light Activated Nanozyme Therapy to Target Brain Tumors

(IN BRIEF) Empa and HOCH Health Ostschweiz have launched a research project to develop nanozyme-based therapies for treating aggressive brain tumors such as astrocytoma, using near-infrared light to activate the treatment directly at the tumor site. The approach aims to … Read the full press release